AzTrials
AzTrials

Condition

Acute Respiratory Distress Syndrome Clinical Trials

Studies of acute respiratory distress syndrome, matched by condition name and medical subject headings. Start with those open to enrolment.

2,063 registered studies

In numbers

Open to volunteers
334
Active
362
With results posted
186
All registered
2,063

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 334
  • Acute Dyspnea, Acute Respiratory Failure

    Diaphragm Response in Elderly for Acute Monitoring

    • Not yet recruiting
    • Age: 75 years and older
    • Observational study

    Acute dyspnea is a common cause of emergency department admissions among elderly patients. Acute respiratory failure is often multifactorial and requires rapid and reliable evaluation.

    Conditions
    Acute Dyspnea, Acute Respiratory Failure, Diaphragmatic Ultrasound
    Trial name
    DREAM (NCT07132268)
    Where
    9 sites in France
    Volunteers
    145 people
    Sponsor
    Centre Hospitalier de Bethune
    Can I take part? DREAM
  • Allogeneic Stem Cell Transplantation, Lung Allograft Transplantation

    Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

    • Recruiting
    • Age: 18 to 100 years
    • Phase 3

    Background: Injury or diseases of the heart and lung can sometimes cause scar tissue (fibrosis) to build up in those organs. Current imaging scans can see this scar tissue once it has formed, but researchers want to find a way to…

    Conditions
    Allogeneic Stem Cell Transplantation, Lung Allograft Transplantation, Interstitial Lung Disease, Acute Lung Injury
    Trial name
    NCT07613099
    Testing
    [18F]FAPI-74, 18F-FAPI-74 PET/CT Imaging
    Where
    United States
    Volunteers
    210 people
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Can I take part? NCT07613099
  • Bronchopulmonary Dysplasia, Pulmonary Hypertension Due to Lung Diseases and Hypoxia

    Ventilator Pressure and Optimization of Compliance and Hemodynamics

    • Recruiting
    • Age: 7 to 30 days

    In preterm infants < 34 weeks' gestation at birth receiving respiratory support with invasive positive pressure ventilation, the positive end-expiratory pressure (PEEP) of best compliance will increase the cardiac output and…

    Conditions
    Bronchopulmonary Dysplasia, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Extreme Prematurity, Ventilator Lung; Newborn
    Trial name
    VPOCH (NCT06512935)
    Testing
    Increase in the PEEP followed by decrease in the PEEP, Decrease in the PEEP followed by increase in the PEEP
    Where
    United States
    Volunteers
    24 people
    Sponsor
    University of Alabama at Birmingham
    Can I take part? VPOCH
  • ARDS, Human

    Pulmonary Immune Cell-microbiome Interactions in ARDS

    • Recruiting
    • Age: 18 years and older
    • Observational study
    • Surgery or procedure

    The overall aim is to compare the composition and spatial heterogeneity of the following in critically ill intensive care unit (ICU) patients: i) immune cell populations and their activation patterns, ii) the surrounding…

    Trial name
    ILLUMINA-1 (NCT05795257)
    Testing
    Bronchoalveolar lavage
    Where
    Denmark
    Volunteers
    40 people
    Sponsor
    Hvidovre University Hospital
    Can I take part? ILLUMINA-1
  • Acute Respiratory Distress Syndrome, Infections

    Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

    • Recruiting
    • Age: 18 years and older
    • Phase 2

    BTI-203 is a randomized, double-blind, placebo-controlled, multicenter, Phase 2 proof-of-concept (POC) study to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS…

    Trial name
    NCT05947955
    Testing
    Rhu-pGSN, normal saline
    Where
    65 sites in United States, Belgium and 11 more
    Volunteers
    600 people
    Sponsor
    BioAegis Therapeutics Inc.
    Can I take part? NCT05947955
  • Septic Shock, Acute Respiratory Distress Syndrome

    CytOSorb TreatMent Of Critically Ill PatientS Registry

    • Recruiting
    • Age: All ages
    • Observational study
    • Medical device

    Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based…

    Conditions
    Septic Shock, Acute Respiratory Distress Syndrome, Trauma, Rhabdomyolysis
    Trial name
    COSMOS (NCT05146336)
    Testing
    CytoSorb
    Where
    28 sites in Austria, Germany and 4 more
    Volunteers
    3,000 people
    Sponsor
    CytoSorbents, Inc
    Can I take part? COSMOS
  • Respiratory Insufficiency

    Bedside Spirometry for Acute Lung Injury

    • Recruiting
    • Age: 18 years and older
    • Medical device

    The diagnosis of Acute Respiratory Distress Syndrome (ARDS) is a syndromic diagnosis that groups together patients who may have very different prognoses and respond differently to the same therapies.

    Trial name
    SPIRALI (NCT07750717)
    Testing
    Hand-held spirometer, NIV
    Where
    2 sites in France
    Volunteers
    30 people
    Sponsor
    Centre Hospitalier Departemental Vendee
    Can I take part? SPIRALI
  • Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Failure (ARF)

    Right Heart Injury Monitoring on ECMO

    • Not yet recruiting
    • Age: 18 years and older
    • Observational study

    This study aims to find out whether it is practical to introduce a consistent monitoring approach to the right side of the heart in patients supported with VV-ECMO.

    Conditions
    Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Failure (ARF), Right Heart Failure, Unspecified
    Trial name
    RHIME (NCT07880730)
    Testing
    Transthoracic echocardiogram, High sensitivity troponin, N-terminal pro-B-type natriuretic peptide
    Where
    United Kingdom
    Volunteers
    30 people
    Sponsor
    Papworth Hospital NHS Foundation Trust
    Can I take part? RHIME
  • ARDS, Human, Lung Ultrasound

    Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome

    • Recruiting
    • Age: 18 to 100 years

    Rationale Acute respiratory distress syndrome (ARDS) is a frequent cause of hypoxemic respiratory failure with a mortality rate of approximately 30%.

    Conditions
    ARDS, Human, Lung Ultrasound, Mechanical Ventilation
    Trial name
    NCT05492344
    Testing
    Personalized ventilation, Standard care
    Where
    11 sites in Belgium, China and 6 more
    Volunteers
    538 people
    Sponsor
    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
    Can I take part? NCT05492344
  • Acute Respiratory Distress Syndrome (ARDS), Acute Hypoxemic Respiratory Failure

    Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure

    • Recruiting
    • Age: 18 years and older
    • Surgery or procedure

    Acute hypoxemic respiratory failure may progress to acute respiratory distress syndrome, a life-threatening condition that often requires mechanical ventilation.

    Trial name
    SVALBARD (NCT07463885)
    Testing
    Spontaneous Ventilation Strategy, Controlled Ventilation Strategy
    Where
    Norway
    Volunteers
    80 people
    Sponsor
    Oslo University Hospital
    Can I take part? SVALBARD

Completed, with results posted

All 132
  • Sars-CoV2, Acute Respiratory Distress Syndrome

    Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)

    • Completed
    • Age: 18 years and older
    • Phase 1/2
    • Results posted

    *At this time, we are only enrolling at Houston Methodist Hospital (HMH)/Baylor College of Medicine (BCM) and are not shipping cells outside of BCM/HMH.* This is a study for patients who have respiratory infection caused by…

    Conditions
    Sars-CoV2, Acute Respiratory Distress Syndrome, COVID-19
    Trial name
    NCT04345601
    Testing
    Mesenchymal Stromal Cells, Supportive Care
    Where
    United States
    Volunteers
    28 people
    Sponsor
    Baylor College of Medicine
    Can I take part? NCT04345601
  • SARS-CoV Infection

    VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study

    • Completed
    • Age: 18 to 100 years
    • Phase 3
    • Results posted

    To demonstrate the efficacy of VERU-111 in the treatment of SARS-Cov-2 Infection by assessing its effect on the proportion of patients who die on study (prior to Day 60).

    Trial name
    VERU-111 (NCT04842747)
    Testing
    VERU-111
    Where
    58 sites in United States, Argentina and 4 more
    Volunteers
    204 people
    Sponsor
    Veru Inc.
    Can I take part? VERU-111
  • Acute Respiratory Distress Syndrome

    Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

    • Completed
    • Age: 18 years and older
    • Phase 2
    • Results posted

    This study will be a multi-center, prospective, randomized, partially double-blind, placebo-controlled Phase II clinical trial of inhaled CO (iCO) for the treatment of ARDS.

    Trial name
    NCT03799874
    Testing
    Inhaled Carbon Monoxide at 200 ppm, Inhaled Medical air
    Where
    7 sites in United States
    Volunteers
    4 people
    Sponsor
    Brigham and Women's Hospital
    Can I take part? NCT03799874
  • Acute Respiratory Distress Syndrome, Acute Lung Injury

    Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress

    • Completed
    • Age: 12 to 80 years
    • Medical device
    • Results posted

    This is a prospective, randomized, two-arm, controlled 30-day investigational pilot trial using the gammaCore Sapphire S non-invasive vagus nerve stimulation (nVNS) device + standard of care (SOC) in newly-hospitalized patients…

    Conditions
    Acute Respiratory Distress Syndrome, Acute Lung Injury, Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Traumatic Brain Injury
    Trial name
    NCT04935697
    Testing
    nVNS, SOC
    Where
    United States
    Volunteers
    3 people
    Sponsor
    Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
    Can I take part? NCT04935697
  • Acute Respiratory Distress Syndrome

    Restore Resilience in Critically Ill Children

    • Completed
    • Age: 6 months to 17 years
    • Results posted

    The study design will allow investigators to describe usual care in each PICU and identify the facilitating and restraining factors impacting the implementation of R2 at each PICU.

    Trial name
    R2 (NCT04695392)
    Testing
    R2 Bundle
    Where
    2 sites in United States
    Volunteers
    56 people
    Sponsor
    University of Pennsylvania
    Can I take part? R2

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in